GI clinical trials
Gastroesophageal
GE
Prior to systemic treatment
1st line
2nd line
3rd line
Any line
Liver
HCC
Peri-OR
Pre-transplant
Any line
1st line
2nd line
Last line
Pancreas
PDAC
Resectable
Locally Advanced unresectable
Any Line Advanced
1L Metastatic
2L+ Metastatic
Non-Therapeutic
Biliary
CCA
Adjuvant
1st line
2nd line
3rd line
Any line
Biomarker
MTAP
CLDN18.2
HER-2 on IHC
HER2
HER2 and PDL1
IDH1
Evidence of FGFR2 gene fusions
Browse by biomarker
Download printable PDF
Trial name
Trial details